Status:
WITHDRAWN
Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)
Lead Sponsor:
Duke University
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The purpose of this single institution pilot study is to determine the feasibility of implementing an eHealth prostate cancer surveillance program through the eVisit electronic medical record patient ...
Detailed Description
Telehealth offers the opportunity to transform cancer surveillance into a patient-centered effort with shared leadership between patient and oncologist. Peer-to-peer electronic communications can impr...
Eligibility Criteria
Inclusion
- ≥ 18 years old with histologically confirmed prostate cancer
- Completed curative intent treatment to the prostate +/- pelvis
- Deemed to be "without evidence of active disease" by treating provider with at least 1 follow up visit 3 or more months after treatment completion
- MyChart account or willingness to open account
- Access to the internet
Exclusion
- Documented extrapelvic metastases
- PSA meeting definition of recurrence (\>0.2 ng/ml for prostatectomy patients or nadir + 2 ng/ml for radiation patients) and rising with doubling time less than 1 year
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04486846
Start Date
June 1 2021
End Date
March 1 2022
Last Update
June 10 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Cancer Institute Cary
Cary, North Carolina, United States, 27518
2
Durham Regional Hospital
Durham, North Carolina, United States, 27704
3
Duke University Medical Center
Durham, North Carolina, United States, 27710
4
Duke Raleigh Hospital
Raleigh, North Carolina, United States, 27609